The SARS-CoV-2 Programmed -1 Ribosomal Frameshifting Element Crystal Structure Solved to 2.09 Å Using Chaperone-Assisted RNA Crystallography
Overview
Biology
Affiliations
The programmed -1 ribosomal frameshifting element (PFSE) of SARS-CoV-2 is a well conserved structured RNA found in all coronaviruses' genomes. By adopting a pseudoknot structure in the presence of the ribosome, the PFSE promotes a ribosomal frameshifting event near the stop codon of the first open reading frame Orf1a during translation of the polyprotein pp1a. Frameshifting results in continuation of pp1a via a new open reading frame, Orf1b, that produces the longer pp1ab polyprotein. Polyproteins pp1a and pp1ab produce nonstructural proteins NSPs 1-10 and NSPs 1-16, respectively, which contribute vital functions during the viral life cycle and must be present in the proper stoichiometry. Both drugs and sequence alterations that affect the stability of the -1 programmed ribosomal frameshifting element disrupt the stoichiometry of the NSPs produced, which compromise viral replication. For this reason, the -1 programmed frameshifting element is considered a promising drug target. Using chaperone assisted RNA crystallography, we successfully crystallized and solved the three-dimensional structure of the PFSE. We observe a three-stem H-type pseudoknot structure with the three stems stacked in a vertical orientation stabilized by two triple base pairs at the stem 1/stem 2 and stem 1/stem 3 junctions. This structure provides a new conformation of PFSE distinct from the bent conformations inferred from midresolution cryo-EM models and provides a high-resolution framework for mechanistic investigations and structure-based drug design.
Lee S, Yan S, Dey A, Laederach A, Schlick T Biochemistry. 2025; 64(4):953-966.
PMID: 39907285 PMC: 11840926. DOI: 10.1021/acs.biochem.4c00641.
Yan S, Schlick T Proc Natl Acad Sci U S A. 2025; 122(4):e2417479122.
PMID: 39854230 PMC: 11789066. DOI: 10.1073/pnas.2417479122.
Haddox H, Angehrn G, Sesta L, Jennings-Shaffer C, Temple S, Galloway J bioRxiv. 2025; .
PMID: 39829847 PMC: 11741320. DOI: 10.1101/2025.01.07.631013.
The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discovery.
Novotny P, Humpolickova J, Novakova V, Stanchev S, Strisovsky K, Zgarbova M J Biol Chem. 2024; 301(1):108079.
PMID: 39675720 PMC: 11773056. DOI: 10.1016/j.jbc.2024.108079.
Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition.
Wu S, Xiao T, Chen H, Li X RNA Biol. 2024; 21(1):1-18.
PMID: 39630134 PMC: 11632750. DOI: 10.1080/15476286.2024.2433830.